- Home
- KRRO vs JHS Comparison
KRRO vs JHS Comparison
Compare KRRO & JHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- JHS
- Stock Information
- Founded
- KRRO 2014
- JHS 1973
- Country
- KRRO United States
- JHS United States
- Employees
- KRRO N/A
- JHS N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- JHS Finance Companies
- Sector
- KRRO Health Care
- JHS Finance
- Exchange
- KRRO Nasdaq
- JHS Nasdaq
- Market Cap
- KRRO 125.4M
- JHS 131.4M
- IPO Year
- KRRO 2019
- JHS N/A
- Fundamental
- Price
- KRRO $12.90
- JHS $11.21
- Analyst Decision
- KRRO Strong Buy
- JHS
- Analyst Count
- KRRO 7
- JHS 0
- Target Price
- KRRO $85.67
- JHS N/A
- AVG Volume (30 Days)
- KRRO 99.7K
- JHS 32.8K
- Earning Date
- KRRO 08-12-2025
- JHS 01-01-0001
- Dividend Yield
- KRRO N/A
- JHS 3.96%
- EPS Growth
- KRRO N/A
- JHS N/A
- EPS
- KRRO N/A
- JHS 0.02
- Revenue
- KRRO $4,821,000.00
- JHS N/A
- Revenue This Year
- KRRO $65.08
- JHS N/A
- Revenue Next Year
- KRRO N/A
- JHS N/A
- P/E Ratio
- KRRO N/A
- JHS $553.50
- Revenue Growth
- KRRO N/A
- JHS N/A
- 52 Week Low
- KRRO $10.29
- JHS $9.76
- 52 Week High
- KRRO $98.00
- JHS $11.25
- Technical
- Relative Strength Index (RSI)
- KRRO 51.40
- JHS 49.06
- Support Level
- KRRO $12.27
- JHS $11.24
- Resistance Level
- KRRO $15.15
- JHS $11.30
- Average True Range (ATR)
- KRRO 1.13
- JHS 0.08
- MACD
- KRRO 0.25
- JHS 0.01
- Stochastic Oscillator
- KRRO 57.01
- JHS 35.14
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About JHS John Hancock Income Securities Trust
John Hancock Income Securities Trust is a United States-based closed-ended diversified management investment company. Its primary objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.